Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy

By Devereux Richard B.   de Faire Ulf   Fyhrquist Frej   Harris Katherine E.   Ibsen Hans   Kjeldsen Sverre E.   Lederballe-Pedersen Ole   Lindholm Lars H.   Nieminen Markku S.   Omvik Per   Oparil Suzanne   Wedel Hans   Hille Darcy A.   Dahlöf Björn  

Current Medical Research and Opinion, Vol. 23, Iss. 2, 2007-02 ,pp. : 259-270

Informa Healthcare

Access to resources Recommend Favorite

A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension

By Oparil S.   Abate N.   Chen E.   Creager M. A.   Galet V.   Jia G.   Julius S.   Lerman A.   Lyle P. A.   Pool J.   Tershakovec A. M.  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 1101-1114

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and safety of losartan 100 mg or losartan 100 mg plus hydrochlorothiazide 25 mg in the treatment of patients with essential arterial hypertension and CV risk factors: obser-vational, prospective study in primary care

By Bönner G.   Smolka W.   Jung C.   Bestehorn K.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 981-990

Informa Healthcare

Access to resources Recommend Favorite

Effects of Losartan Titrated to Losartan/Hydrochlorothiazide and Amlodipine on Left Ventricular Mass in Patients with Mild-to-Moderate Hypertension

By  

Cardiology, Vol. 92, Iss. 2, 2000-03 ,pp. : 110-114

Karger

Access to resources Recommend Favorite

Effects of Telmisartan and Losartan on Left Ventricular Mass in Mild-to-Moderate Hypertension

By  

Cardiology, Vol. 99, Iss. 3, 2003-06 ,pp. : 169-170

Karger

Access to resources Recommend Favorite